← Eichor
Study identifier: NCT06278922 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma

Condition: PTSD · Alcohol; Use, Problem  ·  Sponsor: University of Massachusetts, Worcester

PhaseNA
Planned participants144
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The U.S. Deaf community - a group of more than one million Americans who communicate using American Sign Language (ASL) - experiences nearly triple the rate of lifetime problem drinking and twice the rate of trauma exposure compared to the general population. Although there are several treatments for alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD) in hearing populations, none have been developed for or tested with Deaf clients. To address these barriers, the study team developed Signs of Safety, a Deaf-accessible therapy toolkit for treating AUD and PTSD. Their aims are to conduct a nationwide, virtual clinical trial to compare (1) Signs of Safety with (2) treatment as usual and (3) a no treatment control, to collect data on clinical outcomes, and to explore potential mediators and moderators of outcome.

This description comes directly from the study's public registry record.

Talk to the study team

Melissa L Anderson  ·  508-856-5820  ·  melissa.anderson@umassmed.edu

Kayla Meza  ·  kayla.meza@umassmed.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Massachusetts Medical SchoolWorcester, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06278922